Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.22462/01.03.2021.1

http://scihub22266oqcxt.onion/10.22462/01.03.2021.1
suck pdf from google scholar
33648028!ä!33648028

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33648028      Undersea+Hyperb+Med 2021 ; 48 (1): 1-12
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen #MMPMID33648028
  • Feldmeier JJ; Kirby JP; Buckey JC; Denham DW; Evangelista JS; Gelly HB; Harlan NP; Mirza ZK; Ray KL; Robins M; Savaser DJ; Wainwright S; Bird N; Huang ET; Moon RE; Thom SR; Weaver LK
  • Undersea Hyperb Med 2021[Fir]; 48 (1): 1-12 PMID33648028show ga
  • The SARS-Cov-2 (COVID-19) pandemic remains a major worldwide public health issue. Initially, improved supportive and anti-inflammatory intervention, often employing known drugs or technologies, provided measurable improvement in management. We have recently seen advances in specific therapeutic interventions and in vaccines. Nevertheless, it will be months before most of the world's population can be vaccinated to achieve herd immunity. In the interim, hyperbaric oxygen (HBO2) treatment offers several potentially beneficial therapeutic effects. Three small published series, one with a propensity-score-matched control group, have demonstrated safety and initial efficacy. Additional anecdotal reports are consistent with these publications. HBO2 delivers oxygen in extreme conditions of hypoxemia and tissue hypoxia, even in the presence of lung pathology. It provides anti-inflammatory and anti-proinflammatory effects likely to ameliorate the overexuberant immune response common to COVID-19. Unlike steroids, it exerts these effects without immune suppression. One study suggests HBO2 may reduce the hypercoagulability seen in COVID patients. Also, hyperbaric oxygen offers a likely successful intervention to address the oxygen debt expected to arise from a prolonged period of hypoxemia and tissue hypoxia. To date, 11 studies designed to investigate the impact of HBO2 on patients infected with SARS-Cov-2 have been posted on clinicaltrials.gov. This paper describes the promising physiologic and biochemical effects of hyperbaric oxygen in COVID-19 and potentially in other disorders with similar pathologic mechanisms.
  • |COVID-19/blood/complications/immunology/*therapy[MESH]
  • |Cell Hypoxia[MESH]
  • |Cytokine Release Syndrome/immunology[MESH]
  • |Cytokines/blood[MESH]
  • |Humans[MESH]
  • |Hyperbaric Oxygenation/*methods[MESH]
  • |Hypoxia/therapy[MESH]
  • |Inflammation/therapy[MESH]
  • |Mesenchymal Stem Cells[MESH]
  • |Oxygen Consumption[MESH]
  • |Oxygen/poisoning[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box